Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT).
AuteursNieman LK, Boscaro M, Scaroni C, Deutschbein T, Mezôsi E, Driessens N, Georgescu CE, Motyka M, Hubalewska-Dydejczyk A, Jarzab B, Maiter D, Reincke M, Loli P, Zampetti B, Atmaca A, Badiu C, Beckers A, Bolanowski M, Cavagnini F, Unger N, Giordano R, Hanzu FA, Terzolo M, Nader MB, Sinaii N, Tőke J, Tóth M
Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del.
AuteursRodriguez Mier N, Cuyx S, De Boeck K, Proesmans M, Boon M, Dupont L, Arnauts K, De Wachter E, Van Biervliet S, Lequesne M, Nowé V, Boboli H, Ramalho AS, Vermeulen F
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
AuteursSitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.
AuteursMekinian AM, Georgin-Lavaille S, Ferrada MA, Savic S, Koster MJ, Kosmider O, Comont T, Heilblig M, Arostegui JI, Bosco A, Bourguiba R, Calvo KR, Cargo C, Cattaneo C, Chasset F, Coelho H, Campochiaro C, Crisafulli F, Ducharme-Benard S, Faria R, Franceschini F, Frassi M, Groarke EM, Gurnari C, Hakobyan Y, Jamilloux Y, Jurcut C, Kirino Y, Kulasekararaj A, Kunimoto H, Madigan LM, Mann HF, Marvisi C, Milchert M, Morais S, Sockel K, Muratore F, Nakajima H, Patnaik MM, Regadas L, Robin M, Rutgers A, Salvarani C, Sammel AM, Seebach J, Sujobert P, Tomelleri A, Urbanski G, Vandergheynst F, Vieira R, Viswanatha DS, Więsik-Szewczyk E, Diral E, Terrier B, Patel BA, Fenaux P, Grayson PC, Beck DB
Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.
AuteursBaudry G, Crespo-Leiro MG, Delmas C, Guidetti F, Bravo MJ, Valente F, Cikes M, Girerd N, Gustafsson F, Savarese G, van Laake LW, Hill L, Skibelund AK, Zuckermann A, Metra M, Damman K
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study.
AuteursConti Bellocchi MC, Cattani Mottes M, Blesl A, Cremer A, Festa S, Uzzan M, Cúrdia Gonçalves T, Rispo A, Viganò C, Koutroubakis I, Gravina AG, Pugliese D, Eder P, Vieujean S, Fantini MC, Yzet C, Argyriou K, Pouillon L, Ribaldone DG, Michielan A, Truyens M, Viola A, Savarino EV, Ellul P, Gisbert JP, Spyridon V, Campigotto M, Oliveira R, Variola A, Loy L, Pukitis A, Fragaki M, Guarino AD, Mantaka A, Ramos L, Crinò SF, Ciccocioppo R, Frulloni L, Pandora Study Group
Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B.
AuteursMaurer MS, Berk JL, Damy T, Sheikh FH, González-Costello J, Morbach C, Delgado D, Bondue A, Azevedo O, Poulsen SH, Jankowska EA, Yang L, Bender S, Eraly SA, Jay PY, Vest J, Fontana M
